Patents by Inventor David Huang

David Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220200604
    Abstract: A semiconductor package includes source clock circuitry to generate a source clock signal. Reference clock circuitry generates a reference clock signal. A first timing circuit includes a first source clock input to receive the source clock signal. First fan-out circuitry distributes the received source clock signal as a first distributed clock signal to a first set of clocked devices. A first delay circuit delays the received source clock signal by a first delay value based on a first phase difference between the first distributed clock signal and the reference clock signal.
    Type: Application
    Filed: December 15, 2021
    Publication date: June 23, 2022
    Inventors: Jeffrey Alan Fredenburg, Mohammad Faisal, David Moore, Yu Huang
  • Publication number: 20220193016
    Abstract: Embodiments of the instant disclosure generally concern compositions, preparation and methods of use for inhibitory compounds of C-terminal binding proteins (CtBPs), for example, CtBP1 and CtBP2. Certain embodiments concern administering inhibitory compounds of CtBP1 and/or CtBP2 to a subject to treat or reduce the effects of a brain injury or brain trauma in a subject. In other embodiments, agents for inhibiting CtBP1 and/or CtBP2 to treat a subject having a traumatic brain injury (TBI) can include, but are not limited to a peptide capable of inhibiting CtBP expression and/or activity. In other embodiments, agents for inhibiting CtBP1 and/or CtBP2 to treat a subject having a TBI can include, but are not limited to, E1A peptide, a small molecule, an siRNA or a combination thereof. In certain embodiments, CtBP inhibitory agents can be administered alone or as a combination with other CtBP inhibitors.
    Type: Application
    Filed: March 3, 2022
    Publication date: June 23, 2022
    Inventors: Mingxia HUANG, David NORRIS, Rui ZHAO
  • Publication number: 20220186208
    Abstract: Disclosed herein are methods and devices for preparing a sample of nucleic acid molecules from a biological sample. The methods and devices may perform similarly to or better than standard sample preparation methods. The nucleic acid molecules prepared using the methods and devices provided herein may be utilized for downstream applications, including polymerase chain reaction (PCR).
    Type: Application
    Filed: October 22, 2021
    Publication date: June 16, 2022
    Inventors: David D. SWENSON, Gregory C. LONEY, Valeria REVILLA, Adrienne C. LAM, Helen HUANG, Colin KELLY, Victor BRIONES, Brian CIOPYK, Boris ANDREYEV, Adam DE LA ZERDA, Keith MORAVICK, Jesus CHING, Jennifer ALBRECHT, Ryan CENA, Edward BIBA, Jonathan HONG
  • Patent number: 11357586
    Abstract: Systems and methods for saturated robotic movement are provided. In one aspect, there is provided a robotic system, including a robotic arm configured to control movement of a medical instrument, and a processor configured to: receive a first user input from a user for moving the medical instrument with the robotic arm, determine that moving the robotic arm according to the first user input would cause a contact point of the robotic arm to contact or cross a collision boundary surrounding an object, and guide the movement of the robotic arm such that the contact point of the robotic arm continuously moves along the collision boundary based in part on the first user input, in response to the determination that moving the robotic arm according to the first user input would cause the contact point to contact or cross the collision boundary.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: June 14, 2022
    Assignee: Auris Health, Inc.
    Inventors: Yanan Huang, Nima Sarli, Ying Mao, David Stephen Mintz
  • Patent number: 11357772
    Abstract: Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: June 14, 2022
    Inventors: David Stamler, Michael Huang
  • Publication number: 20220177435
    Abstract: The invention provides therapeutic compositions that contain an inhibitor of dihydroorotate dehydrogenase (DHODH) and promote sustained elevation of dihydroorotate (DHO) levels in a patient. The compositions are useful for treating disorders associated with unregulated DHODH activity, such as acute myeloid leukemia. The invention also provides methods of determining therapeutically effective doses of compositions that contain a DHODH inhibitor. The invention further provides methods of synthesis of 2-(2?-halo-1-1?-biphenyl-4-yl)-quinoline carboxylic acids, which are useful as DHODH inhibitors.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 9, 2022
    Inventors: Vikram S. Kumar, David P. Hesson, Ping Huang, Mo Jia, Xianjun You
  • Patent number: 11355880
    Abstract: A retractable pin includes: a cylindrical body, a retractable member with an insertion cavity at one end, and a spring disposed in a spring cavity defined by the combination of the retractable member and the cylindrical body. Upon application of a force to a free end of the retractable member, the retractable member is configured to retract into the cylindrical body by means of compression of the spring. This invention is further directed to a coaxial connector including a retractable pin as described above.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: June 7, 2022
    Assignee: CommScope Technologies LLC
    Inventors: Mulan Huang, David J. Smentek, Yujun Zhang, Jin Liu
  • Patent number: 11352381
    Abstract: The present invention relates to an improved synthesis of malathion. The presence of an acid facilitates the reaction between O,O-dimethyldithiophosphoric acid (O,O-DMDTPA) and maleate and leads to excellent product yield in shorter reaction time with fewer impurities.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: June 7, 2022
    Assignee: CHEMINOVA A/S
    Inventors: David Huang, Bolin Fan, Kevin Luo
  • Publication number: 20220169734
    Abstract: The disclosure provides antibody agents that bind to a T Cell Immunoglobulin and Mucin Protein-3 (TIM-3) protein. Particular immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide sequences are explicitly provided. Also provided are related nucleic acids, vectors, compositions, and methods of using the anti-TIM-3 antibody agent to treat a disorder or disease that is responsive to TIM-3 inhibition, such as cancer, an infectious disease, or an autoimmune disease.
    Type: Application
    Filed: October 27, 2021
    Publication date: June 2, 2022
    Inventors: David J. King, Marilyn Kehry, Srimoyee Ghosh, Baochuan Huang
  • Publication number: 20220174544
    Abstract: A device may include a processor configured to establish a data traffic flow for a user equipment (UE) device and determine per flow descriptor attributes associated with the data traffic flow, wherein the per flow descriptor attributes identify at least a source, a destination, and a protocol associated with the data traffic flow. The processor may be further configured to determine at least one additional per flow descriptor attribute for the data traffic flow and send the per flow descriptor attributes and the at least one additional per flow descriptor attribute to a network exposure device of a core network, wherein the network exposure device is configured to communicate with servers outside the core network.
    Type: Application
    Filed: November 30, 2020
    Publication date: June 2, 2022
    Inventors: David Taft, Nicklous D. Morris, Parry Cornell Booker, Ye Huang, Jerry Steben, Maqbool Chauhan, Kalyani Bogineni
  • Publication number: 20220169611
    Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Michael D. Bartberger, Ana Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard Victor Connors, Jeffrey Deignan, Jason A. Dequette, I, John Eksterowicz, Benjamin Fisher, Brian M. Fox, Jiasheng Fu, Zice Fu, Felix Gonzalez Lopez De Turiso, Michael W. Gribble, Darin J. Gustin, Julie A. Heath, Xin Huang, XianYun Jiao, Michael G. Johnson, Frank Kayser, David John Kopecky, SuJen Lai, Yihong Li, Zhihong Li, Jiwen Liu, Jonathan D. Low, Brian S. Lucas, Zhihua Ma, Lawrence R. McGee, Josel McIntosh, Dustin L. McMinn, Julio C. Medina, Jeffrey Thomas Mihalic, Steven H. Olson, Yossup Rew, Philip M. Roveto, Daqing Sun, Xiaodong Wang, Yingcai Wang, Xuelei Yan, Ming Yu, Jiang Zhu
  • Publication number: 20220162494
    Abstract: A method of cementing a wellbore includes injecting into the wellbore a non-aqueous fluid; injecting into the wellbore a cement slurry and a non-ionic surfactant composition after injecting the non-aqueous fluid; and allowing the cement slurry to set, wherein the non-ionic surfactant composition comprises an alkyl end-capped ethoxylated fatty alcohol, a chain extended non-ionic surfactant, or a combination comprising at least one of the foregoing.
    Type: Application
    Filed: February 11, 2022
    Publication date: May 26, 2022
    Applicants: Baker Hughes Oilfield Operations LLC, BP EXPLORATION OPERATING COMPANY LIMITED
    Inventors: Angela Anh Doan, Antonio Bottiglieri, Daniel J. Daulton, Cresencio Perez, Shanshan Huang, David James Hoolas, Emmanuel Therond, Paulo Jorge da Cunha Gomes
  • Publication number: 20220160703
    Abstract: The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in immunotherapy, particularly where the disease is accompanied by elevated levels of NQO1. In particular, embodiments where an immunotherapy, such as a heckpoint inhibitor, are combined with a NQO1 bioactivatable drug.
    Type: Application
    Filed: March 18, 2020
    Publication date: May 26, 2022
    Applicants: The Board of Regents of The University of Texas System, Indiana University Research and Technology Corporation, The Board of Trustees of the University of Illinois
    Inventors: Yang-Xin FU, Xiumei HUANG, David BOOTHMAN, Paul J. HERGENROTHER, Xiaoguang LI, Lingxiang JIANG
  • Patent number: 11340918
    Abstract: Certain aspects of the present disclosure provide techniques for generating a user experience for a software program product based on a knowledge engine. Techniques for generating the user experience include a UI builder tool providing a set of tabular UI views and receiving in each tabular UI view corresponding input data for generating a calculation graph, a completeness graph, a client UI view, and a constants table. Based on the input data, the UI builder tool and knowledge engine can generate a set of artifact files. The knowledge engine can generate and/or execute the calculation graph(s), completeness graph(s), and constants table(s) as defined in the corresponding artifact files. The UI builder tool can generate an instance of the client UI view. With the generated calculation graph(s), completeness graph(s), constants table(s), and an instance of the client UI view, the user experience can be provided to a computing device.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: May 24, 2022
    Assignee: INTUIT, INC.
    Inventors: Justin Rui Chang Chiang, Maria Regina Villanueva Garcia, Kevin M. McCluskey, Nankun Huang, David Alan Hanekamp, Jr., Edward Milton Renner, Peter Edward Lubczynski, Matthew Allen Brincho, Tracy Fung
  • Publication number: 20220156745
    Abstract: A method implemented on an augmented reality electronic device includes establishing a wireless connection with an automated teller machine (ATM). The AR electronic device is used to authenticate a user of the AR electronic device at the ATM. An initiation is permitted of a financial transaction through user interface functionality for the ATM that is displayed on the AR electronic device. Financial information for the financial transaction is displayed on a display screen of the AR electronic device, instead of displaying the financial information at the ATM.
    Type: Application
    Filed: February 4, 2022
    Publication date: May 19, 2022
    Inventors: Harlen Bayha, Jennifer Stacey Borchardt, Adam Clifford Christensen, Charles Cowell, Eduardo DeLa Torre, Kourtney Eidam, Darren M. Goetz, Eric David Greene, Robert Glenn Hamchuk, Miranda C. Hill, Pey-Ning Huang, Richard Harrison Luttrell, JR., Orsolya Oldroyd, Paul Vittimberga, Dominik Vltavsky
  • Publication number: 20220114295
    Abstract: Methods, systems, and media for building configuration of one or more buildings are provided.
    Type: Application
    Filed: October 8, 2021
    Publication date: April 14, 2022
    Inventors: Jack Amadeo, Amelia Harvey, Brian Ho, David Huang, Violet Whitney, Luda Zhao
  • Publication number: 20220114296
    Abstract: Methods, systems, and media for generating building layouts are provided.
    Type: Application
    Filed: October 8, 2021
    Publication date: April 14, 2022
    Inventors: Okalo Ikhena, Josh Chappell, Difei Chen, Tess Bianchi, Samara Trilling, Douwe Osinga, Brian Ho, Jack Amadeo, Luda Zhao, David Huang, Amelia Harvey
  • Patent number: 11302043
    Abstract: Disclosed herein are methods and systems for automated detection of shadow artifacts in optical coherence tomography (OCT) and/or OCT angiography (OCTA). The shadow detection includes applying a machine-learning algorithm to the OCT dataset and the OCTA dataset to detect one or more shadow artifacts in the sample. The machine-learning algorithm is trained with first training data from first training samples that include manufactured shadows and no perfusion defects and second training data from second training samples that include perfusion defects and no manufactured shadows. The shadow artifacts in the OCTA dataset and/or OCT dataset may be suppressed to generate a shadow-suppressed OCTA dataset and/or a shadow-suppressed OCT dataset, respectively. Other embodiments may be described and claimed.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: April 12, 2022
    Assignee: Oregon Health & Science University
    Inventors: Acner Camino, David Huang, Yali Jia
  • Publication number: 20220088320
    Abstract: A needle hub assembly for a pen needle includes a needle hub, an inner shield and an outer cover. The open end of the outer cover is closed by a removable seal to access the needle hub. The needle hub has a body with a shoulder and a tower extending from the body for supporting a cannula. The inner shield fits over the tower and the cannula and includes a flange that has an outer dimension complementing the outer dimension of the needle hub and contacts the shoulder of the needle hub in the assembled condition. The outer cover encloses the needle hub and the inner shield and includes a stop member on an inner surface that contacts the flange of the inner shield to capture the inner shield between the shoulder of the needle hub and the outer cover.
    Type: Application
    Filed: December 3, 2021
    Publication date: March 24, 2022
    Inventors: Christopher RINI, Richard KLUG, Ronald PETTIS, David HUANG, Shresta MARIGOWDA, Todd SACK, Mark BOWEN, Matthew ZUSCHLAG, David SCHIFF
  • Patent number: D948290
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: April 12, 2022
    Assignee: RJ BRANDS, LLC
    Inventors: Eli Weiss, Angelika Schubert-Belle, David Huang